Recommended content

Congress asks FDA for hemp-derived cannabinoid powers in spending bill

An influential Republican-controlled House of Representatives committee passed a spending bill on Wednesday that addresses the proliferation of hemp-derived cannabinoid products.

In the Agriculture, Rural Development, and Food and Drug Administration bill approved in a markup hearing, the House Appropriations Committee directed the U.S. Food and Drug Administration “to evaluate the safety implications of … products on the market that contain intoxicating cannabinoids” and prepare a report within six months on “the authorities needed to adequately regulate cannabinoid hemp products.”


The bill would need to pass the full House and be approved by the Senate before heading to President Joe Biden’s desk to be signed into law.

What is Congress’ thought process?

While that’s no guarantee, the bill language does shed light on

Read full article on Marijuana Business Daily

Follow us on Instagram or join us on facebook page

Be first to rate

Marijuana Business Daily

More news